FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020479399> ?p ?o ?g. }

• W2020479399 endingPage "N12" @default.
• W2020479399 startingPage "N11" @default.
• W2020479399 abstract "Recent advances in acute stroke therapy have focused on reperfusion. Reperfusion however, is not always associated with good outcomes. Further improvements in outcome will require a better understanding of the physiology associated with reperfusing ischemic brain tissue. It has been noted that recanalization of an occluded cerebral artery does not guarantee reperfusion of the corresponding cerebral tissue due to microcirculatory constriction. This is known as the “no-reflow phenomenon.” Pericytes play a major role in regulating capillary blood flow and respond to multiple chemical signals originating from the surrounding astrocytes and neurons. Yemisci et al. (Nature Medicine 2009; 15:1031–1037) hypothesized that pericytes contract in response to oxygen and nitrogen radicals in the setting of ischemic brain injury, and do not relax even after recanalization, thus explaining the “no-reflow” phenomenon. They further hypothesize that reversing this contraction may impart a neuroprotective effect. The authors visualized vessels injected with horseradish peroxidase (HRP) after subjecting the brain to 2 hours of ischemia followed by 6 hours of reperfusion. There were significantly more vessel constrictions in the ischemic hemisphere when compared to the contralateral nonischemic hemisphere. Pericytes were then marked with antibodies against α-smooth muscle actin (SMA). Optical sections revealed that the location of the pericytes matched the location of the constrictions. Ischemic-like conditions were created in vitro by placing pericytes in an oxygen-glucose deprived solution, causing a decrease in the luminal diameter of capillaries. The capillaries did not dilate back to normal diameter after reverting to a physiologic solution. The authors then tested the role of oxygen and nitrogen radicals in the ischemia-reperfusion induced pericyte contraction. For this purpose, they added a superoxide scavenger, N-tert-butyl-α-phenylnitrone (PBN), and a low dose of nitric oxide synthase (NOS) inhibitor, Nω-nitro-L-arginine (L-NA) just before reperfusion. Both agents relieved pericyte contraction.FIGURE: Effects of ischemia on pericyte encapsulated microvessels. A, HRP-filed microvessels show discontinuities in ischemic hemispheres in contrast to the slender, thread-like structures in non ischemic hemispheres. B, interruptions in erythrocyte columns in the ischemic hemisphere. C, α-SMA pericytes colocalized with the constrictions. D, E, pericytes (arrows) seen in vitro before and after OGD in isolated mouse retina.As for the specific role of endothelial NOS (eNOS), the authors proved that its inhibition with L-N5-(1-iminoethyl)-ornithine (L-NIO), leads to a suppression of the NO surge in response to ischemia without affecting the basal NO secretion, therefore causing less peroxynitrite formation. L-NIO restored patency of microvessels in ischemic brain. In fact, in vivo injection of peroxynitrite caused pericyte contraction and capillary constriction and its in vitro addition to isolated retina had the same effect. Reoxygenation with the addition of PBN relieved both pericyte contraction and capillary constriction. In contrast, a selective neuronal NOS inhibitor was ineffective when administered in vivo shortly before reperfusion. Interestingly, ischemic volume after ischemia-reperfusion was significantly lower in the groups treated with L-NIO, PBN or L-NA than in the group treated with a saline solution. All 3 agents were found to be equally neuroprotective even though L-NA does not cross the blood-brain barrier. The inhibition of the oxidative-nitrative stress by the aforementioned agents significantly decreased the number of vessels harboring entrapped erythrocytes. Despite recent advances in recanalization techniques, stroke remains the leading cause of disability and the 3rd leading cause of mortality in the United States. Insights gained from this work may pave the way for clinical trials aimed at improving brain tissue perfusion after periods of ischemia. This has implications for acute endovascular stroke therapy, temporary arterial occlusion during aneurysm surgery as well as a plethora of other clinical scenarios in neurosurgery. RUDY J. RAHME BERNARD R. BENDOK" @default.
• W2020479399 created "2016-06-24" @default.
• W2020479399 creator A5018865729 @default.
• W2020479399 creator A5086413305 @default.
• W2020479399 date "2010-02-01" @default.
• W2020479399 modified "2023-10-16" @default.
• W2020479399 title "Beyond Opening a Closed Vessel" @default.
• W2020479399 doi "https://doi.org/10.1227/01.neu.0000367836.52270.55" @default.
• W2020479399 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20087116" @default.
• W2020479399 hasPublicationYear "2010" @default.
• W2020479399 type Work @default.
• W2020479399 sameAs 2020479399 @default.
• W2020479399 citedByCount "0" @default.
• W2020479399 crossrefType "journal-article" @default.
• W2020479399 hasAuthorship W2020479399A5018865729 @default.
• W2020479399 hasAuthorship W2020479399A5086413305 @default.
• W2020479399 hasBestOaLocation W20204793991 @default.
• W2020479399 hasConcept C126322002 @default.
• W2020479399 hasConcept C157767197 @default.
• W2020479399 hasConcept C163415756 @default.
• W2020479399 hasConcept C164705383 @default.
• W2020479399 hasConcept C169760540 @default.
• W2020479399 hasConcept C181199279 @default.
• W2020479399 hasConcept C185592680 @default.
• W2020479399 hasConcept C25498285 @default.
• W2020479399 hasConcept C2775841333 @default.
• W2020479399 hasConcept C2777676563 @default.
• W2020479399 hasConcept C2780114680 @default.
• W2020479399 hasConcept C541997718 @default.
• W2020479399 hasConcept C55493867 @default.
• W2020479399 hasConcept C71924100 @default.
• W2020479399 hasConcept C86803240 @default.
• W2020479399 hasConceptScore W2020479399C126322002 @default.
• W2020479399 hasConceptScore W2020479399C157767197 @default.
• W2020479399 hasConceptScore W2020479399C163415756 @default.
• W2020479399 hasConceptScore W2020479399C164705383 @default.
• W2020479399 hasConceptScore W2020479399C169760540 @default.
• W2020479399 hasConceptScore W2020479399C181199279 @default.
• W2020479399 hasConceptScore W2020479399C185592680 @default.
• W2020479399 hasConceptScore W2020479399C25498285 @default.
• W2020479399 hasConceptScore W2020479399C2775841333 @default.
• W2020479399 hasConceptScore W2020479399C2777676563 @default.
• W2020479399 hasConceptScore W2020479399C2780114680 @default.
• W2020479399 hasConceptScore W2020479399C541997718 @default.
• W2020479399 hasConceptScore W2020479399C55493867 @default.
• W2020479399 hasConceptScore W2020479399C71924100 @default.
• W2020479399 hasConceptScore W2020479399C86803240 @default.
• W2020479399 hasIssue "2" @default.
• W2020479399 hasLocation W20204793991 @default.
• W2020479399 hasLocation W20204793992 @default.
• W2020479399 hasOpenAccess W2020479399 @default.
• W2020479399 hasPrimaryLocation W20204793991 @default.
• W2020479399 hasRelatedWork W1540517858 @default.
• W2020479399 hasRelatedWork W2006800517 @default.
• W2020479399 hasRelatedWork W2122237062 @default.
• W2020479399 hasRelatedWork W2123894485 @default.
• W2020479399 hasRelatedWork W2252574504 @default.
• W2020479399 hasRelatedWork W2373014208 @default.
• W2020479399 hasRelatedWork W2376528074 @default.
• W2020479399 hasRelatedWork W2572779631 @default.
• W2020479399 hasRelatedWork W2789293914 @default.
• W2020479399 hasRelatedWork W3147238946 @default.
• W2020479399 hasVolume "66" @default.
• W2020479399 isParatext "false" @default.
• W2020479399 isRetracted "false" @default.
• W2020479399 magId "2020479399" @default.
• W2020479399 workType "article" @default.